ArticleJournal of the American Heart Association2019

Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin-Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure.

Nancy M Albert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.